What are psoriasis biotherapies?
These innovative and expensive treatments are administered by injection and must be stored in a cool place. They are essentially what are known as monoclonal antibodies that target an inflammation molecule, such as TNF-alpha, IL-23 or more recently IL-17. These drugs reduce psoriasis activity by lowering the levels of the molecules responsible for skin and/or joint inflammation.